(firstQuint)Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis.

 The primary objective was to investigate the efficacy and safety of 0.

05% difluprednate ophthalmic emulsion in patients with endogenous anterior uveitis and to determine its clinical usefulness for treatment of this disease in the early phase of development, in comparison with Rinderon(R) solution (containing 0.

1% betamethasone sodium phosphate) that has widely been used for treatment of postoperative inflammation, uveitis, etc.

 as a steroid ophthalmic solution.

 The secondary objective was to establish the evaluation system for a dose-finding study.

.

 Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis@highlight

The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of uveitis.

